Member Info for Jez2

Hole 5 could be very interesting after hitting mineralisation zone at around 85m if remember correctly! Are they due to be released soon?

Just read a motley fool article, possibly the worst and infactual article I've ever read on sng! If anyone sells on that more fool them lol
They quote "synairgen phase 3 trial due to commence in October" and "just hit they're all time high this week" if I was Richard Marsden I'd sue them..

British bulls have this top of there buy recommendations, currently oversold and looking good for a run back up the charts in anticipation of good news.
https://www.britishbulls.com/m/SignalPage.aspx?lang=en&Ticker=XTR.L

https://www.fiercebiotech.com/biotech/cytodyn-shares-plummet-after-being-accused-by-fda-cherry-picking-covid-19-data

It would be great if the government had a successful treatment to announce with the ending of the current lockdown, that works against variants and will run alongside the vaccination programme into autumn/winter, would certainly calm a few nerves and boost the economy.
To the best of my knowledge they haven't discovered that magic pill yet..

Thanks oak :)

Maybe and this is just a "maybe" they might have just had a sniff of activ-2 news and progress to activ-3 ahead of us and are preparing to take credit.

Thats my point oakleaf, the timing of reposting to remind everyone how much nihr have supported this treatment from the get go.
Makes me think something a lot bigger might be coming very soon.. especially with recent sp behaviour and im sure Mr Johnson and mr handjob will be ready waiting to claim full plaudits.

Twitter link
https://twitter.com/HRA_Latest/status/1399756010168930304?s=19

Posted on twitter 1 hour ago, is someone in government getting ready to claim a uk success story??
https://www.nihr.ac.uk/documents/case-studies/delivering-commercial-urgent-public-health-research-synairgen/25079

Those statements from Richard Marsden are very telling and totally out of character! I think it's a big show of intent to potential buyers who'll be circling synairgen like vultures. 1 billion + sales annually, strongest phase 2 data in the world, transformational, blockbuster!
How much do you want to pay for a 10 billion market cap company is the question?

No they generally mirror us in us a frankfurt as very low volume traded there.
But expecting a positive day here nonetheless.

Synairgen finished up 7.59% on frankfurt exchange today closing at 1.88 euros.

Just highlights that the £50 bullish price target might not be so crazy after all, with a potential 1 billion a year in sales revenue on successful phase 3 trial results.
Thanks for sharing the link. Gl

Smalltrader
The point is the alternatives don't exist.. we have a unique product and delivery method, already in late stage phase 3 trials. The interesting and important paragraph for me

"The market is expected to reach $8.74 billion in 2025 at a CAGR of 3.5%.

The pandemic outbreak of corona virus is expected to drive the growth of interferons market. This is because of the ongoing trials on various drug candidates including interferons as potential therapeutic options for covid-19 treatment. Interferon-beta (IFN-beta) is a naturally occurring protein that controls the body's antiviral responses.

The drug regulators including the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) have approved the initiation of trials evaluating interferons. For example, SNG001 which is an inhalation formulation of interferon-beta-1a that is delivered to the lungs directly via nebulization."

Link to daily mail article 28/05/21
Synairgen soars after encouraging Covid-related lab tests https://www.thisismoney.co.uk/money/investing/article-9629399/Synairgen-soars-encouraging-Covid-related-lab-tests.html?ito=native_share_article-top

3-5 billion is my target price and a fair valuation should synairgen decide to sell to big pharmaceutical. I think this will be inevitable to keep up with large scale future demand. Ofc the buyer will also be looking to quickly expand sng001 in the copd/asthma market as well as COVID-19, influenza and future viral diseases.
This report imo explains exactly how valuable and attractive a proposition synairgen will be to the big player's and our drug sng001 is also mentioned in the report which expects continued growth in interferon treatments Market reaching over 8 billion by 2030.

https://www.businesswire.com/news/home/20210527005512/en/Global-Interferons-Market-Growth-to-2030-with-Roche-Merck-Bristol-Myers-Squibb-Biogen-Bayer-Zydus-Cadila-Novartis-Pfizer-Biosidus-and-Nanoge-Leading-the-Market---ResearchAndMarkets.com

Jockosjungle
interested to know how you come to a valuation of 600m for synairgen? If you feel the need to post such tosh on here, it would be great to know how you've arrived at this figure? which is "substantial" lower than the expert analysts and brooker figures.
Regards

A lot... and expecting india to pick up the last handful over next week or 2. Imo

I've not seen this article posted from yesterday but highlighting the growth of interferon market, interesting reading.
Nice to see synairgen named in there amongst the big pharmaceutical players!
I wonder which one of them will be taking over the reigns here soon...?
https://www.businesswire.com/news/home/20210527005512/en/Global-Interferons-Market-Growth-to-2030-with-Roche-Merck-Bristol-Myers-Squibb-Biogen-Bayer-Zydus-Cadila-Novartis-Pfizer-Biosidus-and-Nanoge-Leading-the-Market---ResearchAndMarkets.com